StockData

Chemed Corp (CHE) stock

CHENYSEServices-Home Health Care ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 17/305% above fair value
$548.20−2.00 (-0.36%)

Close on Nov 13, 2026Market cap $7.13BP/E 26.2Yield 0.40%

Chemed operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Chemed's operating cash flow for the twelve months ending Sep 30, 2026 was $363.16M, down 13.5% year over year. For fiscal 2025 it was $388.27M, down 7.0% from the year before. Over ten years it grew 8.5% a year on average. The highest annual figure on record is $489.29M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$388.27M-7.0%
FY2024Dec 31, 2024$417.50M+26.4%
FY2023Dec 31, 2023$330.30M+6.6%
FY2022Dec 31, 2022$309.89M+0.4%
FY2021Dec 31, 2021$308.60M-36.9%
FY2020Dec 31, 2020$489.29M+62.4%
FY2019Dec 31, 2019$301.25M+4.9%
FY2018Dec 31, 2018$287.14M+76.7%
FY2017Dec 31, 2017$162.50M+20.0%
FY2016Dec 31, 2016$135.39M-21.1%
FY2015Dec 31, 2015$171.50M+55.5%
FY2014Dec 31, 2014$110.28M-26.9%
FY2013Dec 31, 2013$150.85M+14.5%
FY2012Dec 31, 2012$131.77M-24.4%
FY2011Dec 31, 2011$174.34M+102.7%
FY2010Dec 31, 2010$86.01M-46.5%
FY2009Dec 31, 2009$160.83M+43.5%
FY2008Dec 31, 2008$112.08M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$56.59M-32.1%
Q2 FY2026Jun 30, 2026$84.81M-38.8%
Q1 FY2026Mar 31, 2026$88.22M+169.4%
Q4 FY2025Dec 31, 2025$133.53M-19.0%
Q3 FY2025Sep 30, 2025$83.39M-7.9%
Q2 FY2025Jun 30, 2025$138.61M+78.8%
Q1 FY2025Mar 31, 2025$32.74M-61.3%
Q4 FY2024Dec 31, 2024$164.91M+51.9%
Q3 FY2024Sep 30, 2024$90.52M+212.9%
Q2 FY2024Jun 30, 2024$77.52M-41.4%
Q1 FY2024Mar 31, 2024$84.55M+39.8%
Q4 FY2023Dec 31, 2023$108.56M+8.3%
Q3 FY2023Sep 30, 2023$28.93M-44.4%
Q2 FY2023Jun 30, 2023$132.32M+133.9%
Q1 FY2023Mar 31, 2023$60.49M-40.2%
Q4 FY2022Dec 31, 2022$100.20M+57.6%
Q3 FY2022Sep 30, 2022$52.02M-54.0%
Q2 FY2022Jun 30, 2022$56.58M+123.5%
Q1 FY2022Mar 31, 2022$101.09M-5.3%
Q4 FY2021Dec 31, 2021$63.57M-26.8%
Q3 FY2021Sep 30, 2021$112.99M-9.3%
Q2 FY2021Jun 30, 2021$25.32M-86.6%
Q1 FY2021Mar 31, 2021$106.72M+19.5%
Q4 FY2020Dec 31, 2020$86.88M+36.6%
Q3 FY2020Sep 30, 2020$124.59M-3.2%
Q2 FY2020Jun 30, 2020$188.50M+433.7%
Q1 FY2020Mar 31, 2020$89.33M+21.4%
Q4 FY2019Dec 31, 2019$63.60M+12.5%
Q3 FY2019Sep 30, 2019$128.74M+17.5%
Q2 FY2019Jun 30, 2019$35.32M-36.7%
Q1 FY2019Mar 31, 2019$73.59M+12.9%
Q4 FY2018Dec 31, 2018$56.53M–
Q3 FY2018Sep 30, 2018$109.57M+20.9%
Q2 FY2018Jun 30, 2018$55.84M+77.1%
Q1 FY2018Mar 31, 2018$65.19M-5.2%
Q4 FY2017Dec 31, 2017-$28.49M-504.7%
Q3 FY2017Sep 30, 2017$90.67M–
Q2 FY2017Jun 30, 2017$31.54M–
Q1 FY2017Mar 31, 2017$68.79M–
Q4 FY2016Dec 31, 2016$7.04M–

More Chemed figures

See a number that looks wrong?